-
Track & Monitor
NewInnovation in medical: minimally invasive surgical instruments
Our team of industry experts has meticulously researched and analyzed the latest trends, innovations and emerging technologies in the medical industry’s minimally invasive surgical instruments segment. By leveraging our report, you will gain invaluable insights that can revolutionise your business strategies and give you a competitive edge.
-
Track & Monitor
NewInternet of Things in Retail: Automated self-service kiosks
Our team of industry experts has meticulously researched and analyzed the latest trends, innovations and emerging technologies in the retail industry’s Automated self-service kiosks segment. By leveraging our report, you will gain invaluable insights that can revolutionise your business strategies and give you a competitive edge.
-
Track & Monitor
NewRobotics In Construction: Autonomous Excavator
Our team of industry experts has meticulously researched and analyzed the latest trends, innovations and emerging technologies in the construction industry’s Autonomous Excavator segment. By leveraging our report, you will gain invaluable insights that can revolutionise your business strategies and give you a competitive edge.
-
Track & Monitor
NewExtraction technology in mining: extraction by leaching
Our team of industry experts has meticulously researched and analyzed the latest trends, innovations and emerging technologies in the mining industry’s extraction by leaching segment. By leveraging our report, you will gain invaluable insights that can revolutionise your business strategies and give you a competitive edge.
-
Track & Monitor
NewInnovation in power: nuclear reactor cooling systems
Our team of industry experts has meticulously researched and analyzed the latest trends, innovations and emerging technologies in the power industry’s nuclear reactor cooling systems segment. By leveraging our report, you will gain invaluable insights that can revolutionise your business strategies and give you a competitive edge.
-
Sector Analysis
NewUnited States (US) Sports Broadcasting Media (Television and Telecommunications) Market Landscape
The United States Media Landscape Report provides an overview of the television and telecommunications market in relation to sports broadcasting in the United States today, with top-level data and detailed forecasts of key indicators up to 2028. The report analyses the television, SVOD, mobile handset and residential fixed-line broadband sectors, as well as a review of major sports media rights.
-
Sector Analysis
NewQatar Sports Broadcasting Media (Television and Telecommunications) Market Landscape
The Qatar Media Landscape Report provides an overview of the television and telecommunications market in relation to sports broadcasting in Qatar today, with top-level data and detailed forecasts of key indicators up to 2028. The report analyses the television, SVOD, mobile handset and residential fixed-line broadband sectors, as well as a review of major sports media rights.
-
Product Insights
NewNet Present Value Model: Bavarian Nordic AS’s PXVX-0317
Empower your strategies with our Net Present Value Model: Bavarian Nordic AS's PXVX-0317 report and make more profitable business decisions. Evaluating the value of drugs can be complex, involving a deep understanding of the drug, the current market and expected cash flows, expenses, and success rates at each stage of development. Fortunately, GlobalData simplifies this process with meticulously crafted, high-value, risk-adjusted NPV models that incorporate extensive drug intelligence.
-
New
Net Present Value Model: Terns Pharmaceuticals Inc’s TERN-501
Empower your strategies with our Net Present Value Model: Terns Pharmaceuticals Inc's TERN-501 report and make more profitable business decisions. Evaluating the value of drugs can be complex, involving a deep understanding of the drug, the current market and expected cash flows, expenses, and success rates at each stage of development. Fortunately, GlobalData simplifies this process with meticulously crafted, high-value, risk-adjusted NPV models that incorporate extensive drug intelligence.
-
New
Net Present Value Model: Acelyrin Inc’s Izokibep
Empower your strategies with our Net Present Value Model: Acelyrin Inc's Izokibep report and make more profitable business decisions. Evaluating the value of drugs can be complex, involving a deep understanding of the drug, the current market and expected cash flows, expenses, and success rates at each stage of development. Fortunately, GlobalData simplifies this process with meticulously crafted, high-value, risk-adjusted NPV models that incorporate extensive drug intelligence.